Live Breaking News & Updates on Prnewswire Singlera Genomics Inc

Stay updated with breaking news from Prnewswire singlera genomics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Singlera Genomics announces research collaboration with Astellas Pharma pursuing methylation-based tools to better understand biological reactions to pharmaceuticals

/PRNewswire/ Singlera Genomics Inc. today announced a research collaboration with Astellas Pharma Inc. to develop methylation-based tools to better. ....

San Diego , United States , Qiang Liu , Yvonne Jia , Astellas Pharma Inc , Prnewswire Singlera Genomics Inc , Research Development , Singlera Genomics Inc , Astellas Pharma , Singlera Genomics , Early Cancer Screening , Prognosis Monitoring ,

Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products

Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products
News provided by
Share this article
Share this article
SAN DIEGO and SHANGHAI, Dec. 15, 2020 /PRNewswire/ Singlera Genomics Inc. today announced that it raised $150 million in Series B financing. This round of financing was led by the CICC Kai Tak Innovative Biomedicine Fund, and co-led by Detong Capital and Furong Investment. The new group of investors also include Huamei International, Linden Asset Group, Wuxi Capital, FutureX Skyline Capital, Shanghai Free Trade Zone Fund, and initial investors from the Series A round such as Greenpine Capital, Prosperico Ventures, and Proxima Ventures joined with follow-on investment. Singlera will utilize this round of financing mainly to expand the company s early cancer screening product research and development pipeline and focus on promoting product registration and commercializ ....

United States , San Diego , La Jolla , Yvonne Jia , Capital Operations Co Ltd , Prnewswire Singlera Genomics Inc , Microchip Technology , Shanghai Furong Investment Co Ltd , Singlera Genomics Inc , Linden Asset Group , Fudan University , Kai Tak Innovative Biomedicine Fund , Shanghai Free Trade Zone Fund , Kai Tak Fund , Huamei International , Technology Innovation Board , Ningbo Research Institute Of Fudan University , Tak Innovative Biomedicine Fund , Detong Capital , Wuxi Capital , Futurex Skyline Capital , Greenpine Capital , Prosperico Ventures , Proxima Ventures , Singlera Genomics , Johny Zhang ,

Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products

December 15, 2020
SAN DIEGO and SHANGHAI, Dec. 15, 2020 /PRNewswire/ Singlera Genomics Inc. today announced that it raised $150 million in Series B financing. This round of financing was led by the CICC Kai Tak Innovative Biomedicine Fund, and co-led by Detong Capital and Furong Investment. The new group of investors also include Huamei International, Linden Asset Group, Wuxi Capital, FutureX Skyline Capital, Shanghai Free Trade Zone Fund, and initial investors from the Series A round such as Greenpine Capital, Prosperico Ventures, and Proxima Ventures joined with follow-on investment. Singlera will utilize this round of financing mainly to expand the company s early cancer screening product research and development pipeline and focus on promoting product registration and commercialization, as well as expanding prospective studies into pan-cancer early screening. ....

United States , San Diego , La Jolla , Yvonne Jia , Capital Operations Co Ltd , Prnewswire Singlera Genomics Inc , Microchip Technology , Shanghai Furong Investment Co Ltd , Singlera Genomics Inc , Linden Asset Group , Fudan University , Kai Tak Innovative Biomedicine Fund , Shanghai Free Trade Zone Fund , Kai Tak Fund , Huamei International , Technology Innovation Board , Ningbo Research Institute Of Fudan University , Tak Innovative Biomedicine Fund , Detong Capital , Wuxi Capital , Futurex Skyline Capital , Greenpine Capital , Prosperico Ventures , Proxima Ventures , Singlera Genomics , Johny Zhang ,